← Leaderboards
Frank Arnold
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Allergy And Infectious Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Contracts”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,154,975,474
- Leonard Freedman · Leidos Biomedical Research, Inc.$811,365,654
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ContractsClinical TrialsPlantsVaccine ProductionVaccinesProductionProgramsClinical MaterialPreclinical SafetyClinicSafety StudyManufacturing ProcessPlacebosNational Institute Of Allergy And Infectious DiseaseLaboratoriesInfluenza Virus VaccineFormulationStability TestingAssay DevelopmentClinical ResearchRespiratory Syncytial Virus VaccinesBaseUniversal Influenza VaccineAntibody Response
Grant awards (11)
Establishment and operation of a Vaccine Pilot Plant$32,433,046
ZIB · FY2019 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$15,744,618
ZIB · FY2019 · AI · contact PI
Development/production of universal influenza vaccines$10,496,412
ZIB · FY2019 · AI · contact PI
Establishment and operation of a Vaccine Pilot Plant$33,687,835
ZIB · FY2018 · AI · contact PI
Development/production of universal influenza vaccines$18,309,884
ZIB · FY2018 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$14,973,939
ZIB · FY2018 · AI · contact PI
Development of a recombinant trimeric RSV-F vaccine (DS-Cav1)$3,542,377
ZIA · FY2018 · AI · contact PI
Establishment of a Vaccine Pilot Plant$31,080,346
ZIB · FY2017 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$12,709,669
ZIB · FY2017 · AI · contact PI
Development/production of universal influenza vaccines$3,607,128
ZIB · FY2017 · AI · contact PI
Development of a recombinant trimeric RSV-F vaccine (DS-Cav1)$2,456,526
ZIA · FY2017 · AI · contact PI